Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO21460-D1

Biomarker Field of development:

Liver Cancer Therapy Area:

Method Type of patent:

The circular rna circltbp2 as a biomarker and biotarget in

Intrahepatic cholangiocarcinoma (iCCA) is a deadly cancer worldwide with an increasing incidence and limited therapeutic options. Therefore, there is […]

BIO16372-D1

Biomarker Field of development:

Liver Cancer Therapy Area:

Biomarker Type of patent:

Predicting the risk of having hepatocellular carcinoma in cirrhosis

Plasma levels of different sub-populations of microvesicles (endothelial, leukocyte, platelet and hepatocyte) were measured by flow cytometry or ELISA […]

BIO22031-T1

Drug Field of development:

Liver Cancer Therapy Area:

Method Type of patent:

Treatment of liver cancers by disrupting the beta-catenin/tcf-4

Activating mutations in CTNNB1 gene encoding β-catenin is encountered in approximately 30% of hepatocellular carcinoma (HCC) and in more than 80% of […]

BIO21518-T1

Drug Field of development:

Liver Cancer Therapy Area:

Method Type of patent:

Bay-1895344 (elimusertib) from bayer in adult and pediatric liver

Pediatric liver cancers (PLC) are rare tumors. In particular, hepatoblastomas are usually treated with cisplatin-based neoadjuvant chemotherapy […]

147

56

310

46

Our Technology Offers

The circular rna circltbp2 as a biomarker and biotarget in

Predicting the risk of having hepatocellular carcinoma in cirrhosis

Treatment of liver cancers by disrupting the beta-catenin/tcf-4

Bay-1895344 (elimusertib) from bayer in adult and pediatric liver

You might also be interested in

Methods of treating familial adenomatous polyposis

Engraftment of engineered mesenchymal stromal

Composition comprising furin-inhibited car

Methods and pharmaceutical compositions for

Inhibitor of the heterochromatin protein 1 (hp1)

Methods and pharmaceutical compositions for

Method for treating cancer

Methods of treating cancer combining uros

Garp as a biomarker and biotarget in t-cell

Methods for the diagnosis and treatment of t

Methods and pharmaceutical composition for

Methods for the diagnosis and treatment of acute